Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
Medication-related osteonecrosis of the jaw (MRONJ) was first reported more than a decade ago. Since then, numerous cases have been diagnosed. Currently, there are three groups of drugs related to MRONJ: bisphosphonates, denosumab and anti-angiogenic drugs. As MRONJ can lead to debilitating clinical...
Saved in:
Main Author: | Winnie Zee Man Wat (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Controversies in Classification, Management, and Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw
by: Giuliano Ascani, et al.
Published: (2014) -
Medication-related osteonecrosis of the jaw
by: Heliton Spindola Antunes, et al.
Published: (2018) -
Current treatment approaches in medical-related osteonecrosis of the jaw: Literature review
by: Buse KORKUT, et al.
Published: (2022) -
Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan
by: Takahiko Shibahara
Published: (2019) -
Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?
by: Andrea Cassoni, et al.
Published: (2016)